Form 4: Exelon Director Charisse R. Lillie Reports Stock Transactions

Director Charisse R. Lillie reported the acquisition of deferred stock units and phantom share equivalents in Exelon Corp.

Summary

• Charisse R. Lillie, a director at Exelon Corp, reported transactions involving the company's stock.
• On December 31, 2024, she acquired 1,119 deferred stock units at a price of $36.87 per unit.
• Following this transaction, she beneficially owns 7,472 deferred stock units indirectly through the Exelon Corp. Directors Deferred Stock Unit Plan.
• She also directly owns 7,246 common stock shares.
• Additionally, she holds 3,695 deferred phantom share equivalents, which will be settled for cash upon termination of her service to the board.
• The balance of deferred stock units includes 65 shares acquired through automatic dividend reinvestment.
• The balance of phantom share equivalents includes 36 units accrued by the plan administrator on the ex-dividend date.

Sentiment

Score: 7

Explanation: The document is a routine filing of stock transactions by a director, which is neutral to slightly positive as it indicates continued alignment with the company.

Industry Context

This is a routine filing related to insider transactions and is common for directors of publicly traded companies.

Comparison to Industry Standards

• The reporting of stock transactions by directors is a standard practice across all publicly listed companies.
• The use of deferred stock units and phantom shares is a common form of compensation for board members.
• The reporting requirements are consistent with SEC regulations for insider trading.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect standard director compensation practices.

Key Dates

Keywords

Exelon, Director, Stock Units, Phantom Shares, Deferred Compensation, SEC Form 4, Insider Trading